Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|May 18, 2023
Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34Kristin A Altwegg, Uday P Pratap, Zexuan Liu, et al.
Neuro-Oncology Advances|September 6, 2021
Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastomaUday P Pratap, Gangadhara R Sareddy, Zexuan Liu, et al.
Molecular Carcinogenesis|December 25, 2019
PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathwayYiliao Luo, Mengxing Li, Uday P Pratap, et al.
Breast Cancer Research : BCR|April 9, 2022
SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistanceZexuan Liu, Junhao Liu, Behnam Ebrahimi, et al.
Molecular Cancer Therapeutics|July 26, 2023
Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of GlioblastomaUday P Pratap, Michael Tidwell, Henriette U Balinda, et al.
Breast Cancer Research and Treatment|October 15, 2020
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancerMei Zhou, Prabhakar Pitta Venkata, Suryavathi Viswanadhapalli, et al.
Cancer Research Communications|September 11, 2024
PELP1 Is a Novel Therapeutic Target in Hepatocellular CarcinomaKhaled Mohamed Nassar, Xue Yang, Adriana Baker, et al.
Molecular Oncology|October 19, 2023
PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesisXue Yang, Zexuan Liu, Weiwei Tang, et al.
Pageof 10